| Students' perspective on the Dutch National Pharmacotherapy Assessment, a national survey study among final-year medical students | January 2025 | Donker EM, van Rosse F, Janssen BJA, Knol W, Dumont G, van Smeden J, Atiqi R, Hessel M, Richir MC, van Agtmael MA, Kramers C, Tichelaar J; Education committee of the Dutch Society for Clinical Pharmacology and Biopharmacy | 4.3 | Eur J Pharmacol |
| Hospital-wide interventions for reducing or preventing in-hospital prescribing errors: a scoping review | February 2025 | Mahomedradja RF, Wang S, Sigaloff KCE, Tichelaar J, van Agtmael MA. | 3.0 | Expert Opin Drug Saf |
| Understanding factors that influence the drug choice of prescribers: A Q-methodology study | February 2025 | Hartjes MG, Elsevier AEF, Grijpma JWG, Richir MC, van Agtmael MA, Tichelaar J. | 3.1 | Br J Clin Pharmacol |
| The impact of summative, formative or programmatic assessment on the Dutch National Pharmacotherapy assessment: A retrospective multicentre study | February 2025 | Donker EM, van Rosse F, Janssen BJA, Knol W, Dumont G, van Smeden J, Atiqi R, Hessel M, Richir MC, van Agtmael MA, Kramers C, Tichelaar J; Education committee of the Dutch Society for Clinical Pharmacology and Biopharmacy. | 4.3 | Eur J Pharmacol |
| "Doctor, would it surprise you if there were prescribing errors in this patient's medication?" Identifying eligible patients for in-hospital pharmacotherapeutic stewardship: A matched case-control study | March 2025 | Mahomedradja RF, Lissenberg-Witte BI, Sigaloff KCE, Tichelaar J, van Agtmael MA. | 3.1 | Br J Clin Pharmacol |
